KBP-7018 hydrochloride
CAS No. 1613437-67-4
KBP-7018 hydrochloride( KBP 7018 hydrochloride | KBP7018 hydrochloride )
Catalog No. M12342 CAS No. 1613437-67-4
A novel potent, multikinase inhibitor with IC50 of 10, 7.6 and 25 nM for c-Kit, RET and PDGFRβ, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 963 | Get Quote |
|
| 50MG | 1962 | Get Quote |
|
| 100MG | 2520 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameKBP-7018 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel potent, multikinase inhibitor with IC50 of 10, 7.6 and 25 nM for c-Kit, RET and PDGFRβ, respectively.
-
DescriptionA novel potent, multikinase inhibitor with IC50 of 10, 7.6 and 25 nM for c-Kit, RET and PDGFRβ, respectively; also potently inhibits FLT3, VEGFR2, Fyn, PDGFRα and VEGFR2; shows promising outcomes for the treatments of idiopathic pulmonary fibrosis (IPF).
-
In Vitro——
-
In Vivo——
-
SynonymsKBP 7018 hydrochloride | KBP7018 hydrochloride
-
PathwayAngiogenesis
-
Targetc-Kit
-
Recptorc-Kit
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1613437-67-4
-
Formula Weight575.06
-
Molecular FormulaC31H31ClN4O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC(=O)C1=CC2=C(C=C1)C(=C(N2)O)C(=NC3=CC4=C(C=C3)N(CC4)C(=O)CN5CCOCC5)C6=CC=CC=C6.Cl
-
Chemical NameMethyl (Z)-3-(((1-(2-morpholinoacetyl)indolin-5-yl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate hydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Huang Z, et al. ACS Med Chem Lett. 2017 Sep 30;8(11):1142-1147.
2. Huang Z, et al. Drug Des Devel Ther. 2015 Aug 5;9:4319-28.
molnova catalog
related products
-
Cistanoside A
Cistanoside A possesses protective activities on CCl4 induced hepatotoxicity in mice, which is involved with increasing free radicals clearing activities.
-
Bezuclastinib
Bezuclastinib (CGT9486) is a novel, potent and highly selective tyrosine kinase and c-kit D816V inhibitor for the study of advanced mastocytosis.
-
Famitinib
Famitinib (SHR1020) is a structural analogue of sunitinib, novel and potent multi-targeted RTK inhibitor.
Cart
sales@molnova.com